Evidence map›Paper›PMID 27629773›Full record

ArticleBMC cancer2016

microRNA-mediated resistance to hypoglycemia in the HepG2 human hepatoma cell line.

Satomi Ueki, Yuko Murakami, Shoji Yamada, Masaki Kimura, Yoshimasa Saito, Hidetsugu Saito

Abstract read
In one paragraph

Article in BMC cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Satomi UekiDepartment of Pharmacotherapeutics, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, 1058512, Japan.
Yuko MurakamiDepartment of Pharmacotherapeutics, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, 1058512, Japan.
Shoji YamadaDepartment of Pharmacotherapeutics, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, 1058512, Japan.
Masaki KimuraDepartment of Pharmacotherapeutics, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, 1058512, Japan.
Yoshimasa SaitoDepartment of Pharmacotherapeutics, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, 1058512, Japan.
Hidetsugu SaitoDepartment of Pharmacotherapeutics, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, 1058512, Japan. hsaito@a2.keio.jp.ORCID 0000-0002-4816-0770

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is generally accepted that the energy resources of cancer cells rely on anaerobic metabolism or the glycolytic system, even if they have sufficient oxygen. This is known as the Warburg effect. The cells skillfully survive under hypoglycemic conditions when their circumstances change, which probably at least partly involves microRNA (miRNA)-mediated regulation.

methodsTo determine how cancer cells exploit miRNA-mediated epigenetic mechanisms to survive in hypoglycemic conditions, we used DNA microarray analysis to comprehensively and simultaneously compare the expression of miRNAs and mRNAs in the HepG2 human hepatoma cell line and in cultured normal human hepatocytes.

resultsThe hypoglycemic condition decreased the expression of miRNA-17-5p and -20a-5p in hepatoma cells and consequently upregulated the expression of their target gene p21. These regulations were also confirmed by using antisense inhibitors of these miRNAs. In addition to this change, the hypoglycemic condition led to upregulated expression of heat shock proteins and increased resistance to caspase-3-induced apoptosis. However, we could not identify miRNA-mediated regulations, despite using comprehensive detection. Several interesting genes were also found to be upregulated in the hypoglycemic condition by the microarray analysis, probably because of responding to this cellular stress.

conclusionThese results suggest that cancer cells skillfully survive in hypoglycemic conditions, which frequently occur in malignancies, and that some of the gene regulation of this process is manipulated by miRNAs.

Indexed as

ApoptosisBiomarkersCarcinoma, HepatocellularCaspase 3Cell CycleCell Line, TumorCell ProliferationDatabases, Nucleic AcidEpigenesis, GeneticGene Expression ProfilingGene Expression Regulation, NeoplasticGenetic LinkageHepatocytesHep G2 CellsHumansHypoglycemiaBiomarkersCaspase 3MicroRNAsRNA, MessengerHepatomaHypoglycemiaMicroRNAResistance

Identifiers

PMID27629773
PMCPMC5024426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.